Caplight Directory>Investors>Biocodex>Biocodex


Biocodex

Biocodex

Gentilly, Île-de-Francebiocodex.com

Overview

Biocodex is a family-owned pharmaceutical company founded in 1953. Its primary business involves developing and marketing healthcare solutions across three main pillars: microbiota care, women's health, and orphan diseases. Since 2016, the company has also been actively investing in biotech start-ups, particularly those focused on innovative therapeutics involving probiotics or microbial strains, functioning as a corporate venture investor.

Portfolio Companies

2

Investments

CompanyDateStageLead
MRM HealthSep 2025Series BLead
Exeliom BiosciencesJun 2023Series ACo-investor
Exeliom BiosciencesJul 2018Series ACo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersGentilly, Île-de-France
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.